Professor Choi Ha-young of Hallim University's Gangnam Sacred Heart Hospital won a project to support Glocal R&D...a study on bronchiectasis
Sep 18, 2025
Choi Ha-young, a professor of respiratory medicine at Hallym University Gangnam Sacred Heart Hospital (Hospital Director Lee Dong-jin), has been selected as the '2025 Glocal R&D Support Project' among the Ministry of Education's academic research support projects in the field of science and engineering, and will receive a total of 690 million won in research funds for three years.
The research project selected this time is 'Exploration of the intrinsic type of bronchodilator disease and research on customized treatment strategies' and plans to conduct joint research with Professor Park Sang-cheol's research team of otolaryngology (Dr. Da-hee Shim, researcher Ye-eun Park) and cooperate internationally with Professor James Chalmers' research team at the University of Dundee in England.
The prevalence and disease burden of bronchiectasis in Korea are higher than in Western countries due to the influence of respiratory infections such as tuberculosis in the past. However, domestic intermediary studies to identify pathophysiology and appropriate treatment for this are very scarce.
In particular, bronchiectasis can be caused by various causes such as various autoimmune diseases and allergic diseases as well as simple infections, so the heterogeneity of the disease is high. These characteristics have been pointed out as the biggest obstacle to the development of effective treatments.
This study aims to overcome the limitations of existing treatments by establishing treatment strategies tailored to individual characteristics through an intrinsic exploration of segmenting patient populations and finding hidden disease types.
Intrinsic exploration is the process of segmenting patients with bronchiectasis with similar symptoms on the outside to find hidden disease types.
Professor Choi Ha-young said, "This study aims to identify treatable traits through phenotypic and intrinsic search from the perspective of short-duration diseases of bronchodilators and chronic rhinitis and sinusitis. We hope that future research results will lead to patient-specific treatment development and help patients in the actual medical field."
The research project selected this time is 'Exploration of the intrinsic type of bronchodilator disease and research on customized treatment strategies' and plans to conduct joint research with Professor Park Sang-cheol's research team of otolaryngology (Dr. Da-hee Shim, researcher Ye-eun Park) and cooperate internationally with Professor James Chalmers' research team at the University of Dundee in England.
The prevalence and disease burden of bronchiectasis in Korea are higher than in Western countries due to the influence of respiratory infections such as tuberculosis in the past. However, domestic intermediary studies to identify pathophysiology and appropriate treatment for this are very scarce.
In particular, bronchiectasis can be caused by various causes such as various autoimmune diseases and allergic diseases as well as simple infections, so the heterogeneity of the disease is high. These characteristics have been pointed out as the biggest obstacle to the development of effective treatments.
This study aims to overcome the limitations of existing treatments by establishing treatment strategies tailored to individual characteristics through an intrinsic exploration of segmenting patient populations and finding hidden disease types.
Intrinsic exploration is the process of segmenting patients with bronchiectasis with similar symptoms on the outside to find hidden disease types.
Professor Choi Ha-young said, "This study aims to identify treatable traits through phenotypic and intrinsic search from the perspective of short-duration diseases of bronchodilators and chronic rhinitis and sinusitis. We hope that future research results will lead to patient-specific treatment development and help patients in the actual medical field."
|
This article was translated by Naver AI translator.
